Aaron D. Schuler - Concepedia

Author

Aaron D. Schuler

Syntrix Biosystems (United States)

Also Known As

A Schuler, A. Schuler, Aaron D Schuler, Aaron D. Schuler, Aaron Schuler, Schuler, A.D.

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Syntrix Biosystems (United States)University of Washington Montana State University Fred Hutch Cancer Center Infectious Disease Research Institute

About

Aaron D. Schuler is an author at Syntrix Biosystems (United States) specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	554
2	Natural Sciences	4	4	786
3	Biochemistry	4	4	503
4	Health Sciences	1	1	15
5	Cell Biology	1	1	460

Aaron D. Schuler

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes Birgit Heltweg, Tonibelle Gatbonton, Aaron D. Schuler, Cancer Research Drug TargetAntitumor ActivityApoptosisImmunologyCell Death	2006	460
Computational redesign of protein-protein interaction specificity Tanja Kortemme, Łukasz A. Joachimiak, Alex N. Bullock, Nature Structural & Molecular Biology InteractomicsProtein FoldingNatural SciencesMolecular BiologyProtein Modeling	2004	298
Development of Pyrazolone and Isoxazol-5-one Cambinol Analogues as Sirtuin Inhibitors Sumit Mahajan, Michele Scian, Smitha Sripathy, Journal of Medicinal Chemistry	2014	122
PhotoMorphs™: A novel light‐activated reagent for controlling gene expression in zebrafish Amber J. Tomasini, Aaron D. Schuler, John A. Zebala, genesis	2009	60
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas A G Zeimet, Elisabeth Müller‐Holzner, Aaron D. Schuler, Gene Therapy Ovarian CarcinomasGynecologyGene DeliveryAdenoviral VectorsGene Vector	2002	51
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2 Dean Y. Maeda, Angela M. Peck, Aaron D. Schuler, Journal of Medicinal Chemistry	2014	38
Intestinal Transport of Aminopterin Enantiomers in Dogs and Humans with Psoriasis Is Stereoselective: Evidence for a Mechanism Involving the Proton-Coupled Folate Transporter Alan Menter, Breck Thrash, Christina Cherian, Journal of Pharmacology and Experimental Therapeutics	2012	23
Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials John A. Zebala, Shawn Searle, Lynn R. Webster, Journal of Pain	2019	15
Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist John A. Zebala, Aaron D. Schuler, Stuart J. Kahn, Frontiers in Pharmacology Large OverdoseMolecular PharmacologyBiochemistryMedicinePain Medicine	2020	15
Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding model Dean Y. Maeda, Angela M. Peck, Aaron D. Schuler, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMetabolic StabilityBiochemistryFunctional SelectivityVivo Evaluation	2015	14

Page 1